Alto Ingredients Inc ALTO Q1 2026 Earnings Surprise Profit on Strong Cost Management and Improved Margins BeyondSpring Q1 2026 Earnings Narrowed Loss Per Share and Positive Stock Movement PROG Holdings Q1 2026 Earnings Massive EPS Beat Drives Investor Caution Despite Strong Performance HYPD Q1 2026 Earnings Significant EPS Miss Weighs on Investor Sentiment MDLZ Q1 2026 Earnings Strong EPS Beat Amidst Cost Discipline QSI Q1 2026 Earnings NarrowerthanExpected Loss Drives Stock Higher AMPH Q1 2026 Earnings EPS Misses Estimates as Amphastar Faces Operational Pressures MOMO Q4 2025 Earnings Significant EPS Miss Despite Positive Stock Movement Milestone Pharmaceuticals MIST Q1 2026 Earnings EPS Miss Deepens as ClinicalStage Biotech Navigates Development Path ARDX Q1 2026 Earnings EPS Misses Estimates by 142 Revenue Not Disclosed ATAI Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances CDZIP Q1 2026 Earnings NarrowerThanExpected Loss Reflects Cost Discipline Amid Water Resource Development